R-Biopharm, Inc.

Washington, MO

UEI
E9NXLK97A3Q3
CAGE
3NBU7
Primary NAICS
325413 In-Vitro Diagnostic Substance Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
870 Vossbrink Dr, Washington, MO 63090, USA
Website
r-biopharm.com
Founded
1988
Employees
1K-5K
Estimated annual revenue
$250M-$500M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 -$61

Contract awards

Award Agency Obligated Awarded
Elisa kits 75F40118P10273 Food and Drug Administration $16,000
Milk, EGG, peanut LFD kits HHSF223201610479P Food and Drug Administration $23,000
N1402 rida quick norovirus N0018315P1550 Bureau of Medicine and Surgery (Navy) $4,187
R-biopharm quote 818 item R7021 ridascreen gliadin competitive 2ND GEN HHSF223201510074P Food and Drug Administration $9,335
EGG protein detection kits HHSF223201400286P Food and Drug Administration $24,350

Latest 5 listed here. See the rest on GovTribe.

Quick answers

Is R-Biopharm, Inc. registered in SAM.gov?

Yes. R-Biopharm, Inc.'s SAM.gov registration is active through July 17, 2027.

What is R-Biopharm, Inc.'s most recent federal award?

R-Biopharm, Inc.'s most recent federal contract award is Elisa kits (75F40118P10273), from Food and Drug Administration, on August 24, 2018.

On GovTribe

See R-Biopharm, Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors